Stada-led €4bn loan spree could push lev pricing wider
The European leveraged finance market is set to contend with loan deals approaching €4bn for the start of September. Over half of that is for the German pharmaceutical firm Stada — a deal that could help make funding more expensive for everyone else, writes Victor Jimenez.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: